rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Erez Chimovits

Director

Company insider

Files Form 4 as: Director, Andrx Corp /de/; Director and 10% owner, Braveheart Bio; Director and 10% owner, Upstream Bio; Director and 10% owner, BiomX; Director and 10% owner, Adicet Bio; Director and 10% owner, LogicBio Therapeutics; Director and 10% owner, Eledon Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
72
Buys
13
Sells
0
Bought
$101.9M
Sold
$0
Companies
7
Companies where not an officer
7
First trade
18 Oct 2018
Last trade
28 Sep 2026
Last filed
30 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Andrx Corp /de/Director · last 28 Sep 20261 buy · 0 sells
BRVE Braveheart BioDirector, 10% owner · Biotechnology · last 7 Aug 20261 buy · 0 sells
UPB Upstream BioDirector, 10% owner · Biotechnology · last 9 Jun 20261 buy · 0 sells
BiomXDirector, 10% owner · Biotechnology · last 15 Mar 20247 buys · 0 sells
ACET Adicet BioDirector, 10% owner · Biotechnology · last 12 Feb 20210 buys · 0 sells
LogicBio TherapeuticsDirector, 10% owner · last 1 Oct 20202 buys · 0 sells
ELDN Eledon PharmaceuticalsDirector, 10% owner · Biotechnology · last 14 Jan 20201 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—7,127,019filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—1,333,975filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—513,067filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—7,127,019 at $0.00filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—1,333,975 at $0.00filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—513,067 at $0.00filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—256,448 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—256,448filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Bought$1.0M61,516 at $17.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—7,127,019 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—1,333,975 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—513,067 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—256,448 at $0.00filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx PharmaceuticalsBiotechnologySEC FORM 4 Code C—7,127,019filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx PharmaceuticalsBiotechnologySEC FORM 4 Code C—1,333,975filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx PharmaceuticalsBiotechnologySEC FORM 4 Code C—513,067filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx PharmaceuticalsBiotechnologySEC FORM 4 Code C—256,448filing
28 Sep 2026filed 30 Sep 2026ADRX ADARx PharmaceuticalsBiotechnologySEC FORM 4 Bought$1.0M61,516 at $17.00filing
7 Aug 2026filed 11 Aug 2026BRVE Braveheart BioBiotechnologySEC FORM 4 Code C—9,132,420filing
7 Aug 2026filed 11 Aug 2026BRVE Braveheart BioBiotechnologySEC FORM 4 Bought$30.0M1,666,667 at $18.00filing

Sectors

Health Care11
Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Carl L. GordonDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
ORBIMED ADVISORS LLCDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
LAV Biosciences Fund V, L.P.10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
SR ONE CAPITAL MANAGEMENT, LLC10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Simeon GeorgeDirector · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Aaron DeykinChief Medical Officer · Also traded UPB in the last 90 days
Adam HoughtonChief Business Officer · Also traded UPB in the last 90 days
Allison AmbroseGeneral Counsel · Also traded UPB in the last 90 days